tiprankstipranks
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market

Cardiol Therapeutics (CRDL) Ownership - Who Owns Cardiol Therapeutics?

619 Followers

Cardiol Therapeutics (CRDL) Ownership Overview

2.25%0.05%21.23%0.77%75.72%
21.23% Other Institutional Investors
0.77% ETFs
75.72% Public Companies and
Individual Investors
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 22.04% of the company’s stock is owned by Institutional Investors, 2.25% is owned by Insiders, and 75.72% is owned by Public Companies and Individual Investors.
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 21.27% of the company’s stock is owned by Institutional Investors, 2.25% is owned by Insiders, and 0.77% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 23, 2025
xxxxxxxxxxxxx
$50000
Oct 23, 2025
xxxxxxxxxxxxx
$100000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,344,500Insider1.17%1,425,170
881,998Institution0.77%934,918
669,947Insider0.58%710,144
309,309Insider0.27%327,868
133,334Insider0.12%141,334
133,334Insider0.12%141,334
52,435Institution0.05%55,581

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
52,435Institution0.05%55,581

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Cardiol Therapeutics (CRDL)?
According to the latest TipRanks data, approximately 21.23% of the company's stock is held by institutional investors, 2.25% is held by insiders, and 75.72% is held by retail investors.
    What percentage of Cardiol Therapeutics (CRDL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 21.23% of Cardiol Therapeutics (CRDL) stock is held by institutional investors.
      What percentage of Cardiol Therapeutics (CRDL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 75.72% of Cardiol Therapeutics (CRDL) stock is held by retail investors.
        Who owns the most shares of Cardiol Therapeutics (CRDL)?
        David Elsley owns the most shares of Cardiol Therapeutics (CRDL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.